All In Biotech

Drug Trial Radar · NCT05675410

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,875 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,875

Planned (sponsor's estimate)

Start

May 11, 2023

Primary completion

Apr 28, 2031

Study completion Apr 28, 2031

Sponsor

Sponsor type
NIH
First posted
Jan 9, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is in a class of medications called antibody-drug conjugates. It is made of a monoclonal antibody called brentuximab that is linked to a cytotoxic agent called vedotin. Brentuximab attaches to CD30 positive lymphoma cells in a targeted way and delivers vedotin to kill them. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs such as doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine, and procarbazine hydrochloride work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Vincristine is in a class of medications called vinca alkaloids. It works by stopping cancer cells from growing and dividing and may kill them. Prednisone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Adding immunotherapy to the standard treatment of chemotherapy with or without radiation may increase survival and/or fewer short-term or long-term side effects in patients with classical Hodgkin lymphoma compared to the standard treatment alone.

Conditions

  • Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Interventions

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • Bleomycin SulfateBiological

    Given IV

  • Brentuximab VedotinDrug

    Given IV

  • Computed TomographyProcedure

    Undergo CT and/or PET-CT

  • CyclophosphamideDrug

    Given IV

  • DacarbazineDrug

    Given IV

  • Doxorubicin HydrochlorideDrug

    Given IV

  • EtoposideDrug

    Given IV

  • Etoposide PhosphateDrug

    Given IV

  • Fludeoxyglucose F-18Other

    Undergo FDG-PET

  • Involved-site Radiation TherapyRadiation

    Undergo ISRT

  • Magnetic Resonance ImagingProcedure

    Undergo MRI and/or PET-MRI

  • NivolumabBiological

    Given IV

  • Positron Emission TomographyProcedure

    Undergo FDG-PET, PET, PET-CT, and/or PET-MRI

  • PrednisoloneDrug

    Given PO

  • PrednisoneDrug

    Given PO

  • Procarbazine HydrochlorideDrug

    Given PO

  • Questionnaire AdministrationOther

    Ancillary studies

  • Vinblastine SulfateDrug

    Given IV

  • Vincristine SulfateDrug

    Given IV

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS) in rapid early responder (RER) patientsTime frame: From the time of randomization to the earliest time of disease relapse, progression, or death due to any cause, assessed up to 3 years after the randomization of the last patient or when reaching 124 events, whichever comes first
  2. PFS in slow-early responder (SER) patientsTime frame: From the time of randomization to the earliest time of disease relapse, progression, or death due to any cause, assessed up to 3 years after the randomization of the last patient or when reaching 71 events, whichever comes first

Locations

419 sites in 3 countries. Site status is shown where the registry gives one.

  • Children's Hospital of Alabama

    Birmingham, Alabama · Recruiting

  • USA Health Strada Patient Care Center

    Mobile, Alabama · Recruiting

  • Providence Alaska Medical Center

    Anchorage, Alaska · Recruiting

  • CTCA at Western Regional Medical Center

    Goodyear, Arizona · Recruiting

  • Banner Children's at Desert

    Mesa, Arizona · Recruiting

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona · Recruiting

  • Phoenix Childrens Hospital

    Phoenix, Arizona · Recruiting

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Mercy Cancer Center - Carmichael

    Carmichael, California · Recruiting

  • Mercy San Juan Medical Center

    Carmichael, California · Recruiting

  • City of Hope Corona

    Corona, California · Recruiting

  • UC Irvine Health Cancer Center-Newport

    Costa Mesa, California · Recruiting

  • Kaiser Permanente Downey Medical Center

    Downey, California · Recruiting

  • City of Hope Comprehensive Cancer Center

    Duarte, California · Recruiting

  • Kaiser Permanente Dublin

    Dublin, California · Recruiting

  • Mercy Cancer Center - Elk Grove

    Elk Grove, California · Recruiting

  • Kaiser Permanente-Fremont

    Fremont, California · Recruiting

  • Kaiser Permanente Fresno Orchard Plaza

    Fresno, California · Suspended

  • Kaiser Permanente-Fresno

    Fresno, California · Recruiting

  • City of Hope Seacliff

    Huntington Beach, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • City of Hope at Irvine Lennar

    Irvine, California · Recruiting

  • City of Hope Antelope Valley

    Lancaster, California · Recruiting

  • Loma Linda University Medical Center

    Loma Linda, California · Recruiting

  • Miller Children's and Women's Hospital Long Beach

    Long Beach, California · Recruiting

  • City of Hope at Long Beach Elm

    Long Beach, California · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Valley Children's Hospital

    Madera, California · Recruiting

  • Kaiser Permanente- Modesto MOB II

    Modesto, California · Suspended

  • Kaiser Permanente-Modesto

    Modesto, California · Recruiting

  • City of Hope Newport Beach

    Newport Beach, California · Recruiting

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • Children's Hospital of Orange County

    Orange, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Recruiting

  • Mercy Cancer Center - Rocklin

    Rocklin, California · Recruiting

  • Kaiser Permanente Downtown Commons

    Sacramento, California · Recruiting

  • Mercy Cancer Center - Sacramento

    Sacramento, California · Recruiting

  • Sutter Medical Center Sacramento

    Sacramento, California · Recruiting

  • Kaiser Permanente-South Sacramento

    Sacramento, California · Recruiting

Showing 40 of 419 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.